Analysts’ New Coverage for September 8th (AKBA, AME, ARWR, BTBT, CRCL, EVLV, FDXF, GLW, HE, IEX)

Analysts’ new coverage for Tuesday, September 8th:

Westpark Capital started coverage on shares of Akebia Therapeutics (NASDAQ:AKBA). The firm issued a buy rating and a $4.50 target price on the stock.

Vertical Research initiated coverage on shares of AMETEK (NYSE:AME). The firm issued a buy rating and a $255.00 target price on the stock.

Citigroup Inc. started coverage on shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR). Citigroup Inc. issued a buy rating and a $108.00 price target on the stock.

HC Wainwright started coverage on shares of Bit Digital (NASDAQ:BTBT). The firm issued a buy rating and a $4.00 target price on the stock.

Keefe, Bruyette & Woods initiated coverage on shares of Circle Internet Group (NYSE:CRCL). They issued a market perform rating and a $105.00 target price on the stock.

LADENBURG THALM/SH SH initiated coverage on shares of Evolv Technologies (NASDAQ:EVLV). The firm issued a buy rating and a $8.00 target price on the stock.

JPMorgan Chase & Co. initiated coverage on shares of FedEx Freight (NYSE:FDXF). JPMorgan Chase & Co. issued an overweight rating and a $160.00 target price on the stock.

China Renaissance began coverage on shares of Corning (NYSE:GLW). The firm issued a buy rating and a $238.00 target price on the stock.

LADENBURG THALM/SH SH assumed coverage on shares of Hawaiian Electric Industries (NYSE:HE). LADENBURG THALM/SH SH issued a sell rating and a $7.00 target price on the stock.

Vertical Research initiated coverage on shares of IDEX (NYSE:IEX). Vertical Research issued a buy rating and a $250.00 target price on the stock.

Roth Capital assumed coverage on shares of Tempus AI (NASDAQ:TEM). The firm issued a neutral rating and a $67.00 price target on the stock.